BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study

por Zacay, Galia, Shasha, David, Bareket, Ronen, Kadim, Itai, Hershkowitz Sikron, Fabienne, Tsamir, Judith, Mossinson, David, Heymann, Anthony D
Publicado 2021

Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study

por Shasha, David, Bareket, Ronen, Sikron, Fabienne Hershkowitz, Gertel, Omer, Tsamir, Judith, Dvir, David, Mossinson, David, Heymann, Anthony D., Zacay, Galia
Publicado 2022

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel

por Reicher, Shay, Ratzon, Ronit, Ben-Sahar, Shay, Hermoni-Alon, Sharon, Mossinson, David, Shenhar, Yotam, Friger, Michael, Lustig, Yaniv, Alroy-Preis, Sharon, Anis, Emilia, Sadetzki, Siegal, Kaliner, Ehud
Publicado 2021